Corporate Tech Investors

Gen-Probe

Gen-Probe is a corporate venture capital group that invests in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human diseases and screen donated human blood. NATs harness the power of biotechnology to detect diseases more rapidly and/or accurately than older testing methods, and have therefore become one of the fastest-growing segments of the in vitro diagnostics industry.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/28/2011

Transaction History

Our records indicate that Gen-Probe invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Carl Hull

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Gen-Probe has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Gemini Trust Company | Genentech

Share this article

About Our Corporate Tech Investor Database

This corporate tech investor profile is powered by VentureDeal.com, a market leader in strategic investor transaction data for corporations that invest in the tech sector.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary